Study on direct economic burden and influencing factors in patients with cervical cancer and precancerous lesions
10.3760/cma.j.issn.0253-9624.2018.12.017
- VernacularTitle: 子宫颈癌及癌前病变患者直接经济负担及其影响因素研究
- Author:
Siyuan TAO
1
;
Jieru PENG
;
Ying WANG
;
Guiting ZHANG
;
Zhiyu CHEN
;
Fei ZHAO
;
Jianqiao MA
;
Xue YANG
;
Youlin QIAO
;
Fanghui ZHAO
;
Chunxia YANG
Author Information
1. Department of Epidemiology and Biostatistics, West China School of Public Health, Sichuan University, Chengdu 610041, China
- Publication Type:Journal Article
- Keywords:
Uterine cervical neoplasms;
Economics, medical;
Influencing factor
- From:
Chinese Journal of Preventive Medicine
2018;52(12):1281-1286
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To account the direct cost of uterine cervix carcinoma treatment in China and to explore the related factors which influence the direct financial burden of the disease.
Methods:Data was collected through the medical record system and telephone interviews in 14 county-level hospitals and 9 provincial and municipal hospitals from 14 provinces/municipalities enrolled in the Chinese National Health Industry Research Project in 2015. The direct financial burden of uterine cervix carcinoma treatment consisted of the direct medical cost and the direct non-medical cost of treatment in different pathological cervical cancer stages and precancerous lesions. Multiple liner regression method was used to analyze the factors affecting the costs.
Results:The age of the 3 246 patients was (46.40±10.43) years, including 2 423 patients from provincial and municipal hospitals and 823 patients from county-level hospitals. The direct financial burden for one patient of pathological uterine cervix carcinoma stage or precancerous lesion ranged from 10 156.3 yuan to 75 716.4 yuan in provincial and municipal hospitals, and for patients from county-level hospitals, the cost was between 4 927.9 yuan and 47 524.8 yuan per person. There was a wide gap between the direct financial burden of patients in different disease stages. The direct financial burden of patients with precancerous lesions ranged from 4 927.9 yuan per person to 11 243.0 yuan per person, as for patients of pathological uterine cervix carcinoma stages, the direct financial burden was between 29 274.6 yuan and 75 716.4 yuan per person. The factors which influence direct financial burden would include: the levels of the hospital, pathological period, medicare reimbursement, days of treatment, and the methods of treatment (P<0.001).
Conclusion:The direct financial burden of diseases in patients with pathological uterine cervix carcinoma stage or precancerous lesion differed in different levels of hospital and pathological periods. In addition, medicare reimbursement, days of treatment, and the methods of treatment all had impact on it.
